IP Library Granted Patent US 9,888,937
Granted Patent B2
US 9,888,937 · App. 14/830,315 · Granted Feb 13, 2018

System and method for minimally invasive tissue treatment using ultrasonic cannula

Inventors: Jagjit Gill (Lake Forest, CA); Darryl E. Barnes (Rochester, MN); Jay Smith (Rochester, MN); William Wilemon (Laguna Niguel, CA)
Assignee: Tenex Health, Inc.
A61B17/320068A61B8/4444A61B17/3205A61B90/20A61B2017/320084A61B2090/378
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,888,937
App. No.
14/830,315
Granted
Feb 13, 2018
Kind
B2
Abstract

Delivering ultrasonic energy to a target musculoskeletal tissue site includes connecting a delivery device to a vacuum source, a fluid source, and a power signal source. The delivery device has a housing portion maintaining an ultrasound transducer and a tip portion having a sleeve and a cannula. The cannula is coupled to the ultrasound transducer and received in the sleeve to define a covered portion and an exposed portion. Ultrasonic energy is generated by sending a power signal from the power signal source to the ultrasound transducer. The ultrasonic energy is transmitted from the ultrasound transducer to the cannula, such that the exposed portion of the cannula delivers ultrasonic energy at a frequency that is pre-selected to debride musculoskeletal tissue upon percutaneous insertion of the tip portion.

Claims (38)

1. A method of delivering ultrasonic energy for a debridement of musculoskeletal tissue, the method comprising:

connecting a delivery device to a vacuum source, a fluid source, and a power signal source;

generating ultrasonic energy by sending a power signal from a power signal source to an ultrasonic transducer that is secured coaxially about a mounting post, the transducer and mounting post being contained within a housing;

transmitting the ultrasonic energy from the ultrasonic transducer to a cannula, at least a portion of the cannula also being contained within the housing;

percutaneously inserting at least a portion of the cannula proximal to a musculoskeletal tissue site;

delivering fluid from a fluid source to an exposed portion of the cannula; and

activating a vacuum source to remove fluid delivered from the fluid source,

wherein the vacuum source is inactivated if fluid flow to the vacuum source is undesirably reduced;

wherein the exposed portion of the cannula is optimized to deliver ultrasonic energy at a frequency of 25 kHz to 29 kHz; and

wherein the exposed portion of the cannula is imaged by an ultrasound imaging device during the insertion and the debridement of the musculoskeletal tissue.

2. The method of claim 1 , wherein the delivery device is integrally connected to a removable cassette, wherein the removable cassette provides the connection between the delivery device and the vacuum source, the fluid source, and the power signal source.

3. The method of claim 2 , wherein the delivery device and the removable cassette are disposable.

4. The method of claim 2 further comprising replacing the delivery device and removable cassette with a second delivery and a second removable cassette, wherein the second delivery device is integrally connected to the second removable cassette.

5. The method of claim 4 , wherein the second delivery device and the second removable cassette are disposable.

6. The method of claim 1 , wherein fluid flow to the vacuum source is undesirably reduced when there is an occlusion in the fluid flow to the vacuum source.

7. The method of claim 1 , wherein fluid flow to the vacuum source is undesirably reduced when there is an interruption in the fluid flow from the fluid source.

8. The method of claim 1 , further comprising percutaneously inserting the tip portion to a musculoskeletal tissue site.

9. The method of claim 8 , further comprising debriding musculoskeletal tissue with the ultrasonic energy delivered from the cannula while ultrasonically imaging the tip portion of the delivery device.

10. The method of claim 1 , wherein the exposed portion of the cannula comprises a tip that is cylindrical and does not have serrated edges.

11. A method of delivering ultrasonic energy for a debridement of musculoskeletal tissue, the method comprising:

connecting a delivery device to a vacuum source, a fluid source, and a power signal source;

generating ultrasonic energy by sending a power signal from a power signal source to an ultrasonic transducer that is secured coaxially about a mounting post, the transducer and mounting post being contained within a housing;

transmitting the ultrasonic energy from the ultrasonic transducer to a cannula, the ultrasonic energy being delivered to the musculoskeletal tissue from an exposed portion of the cannula, at least a portion of the cannula also being contained within the housing;

percutaneously inserting at least a portion of the cannula proximal to a musculoskeletal tissue site;

delivering fluid from a fluid source to the exposed portion of the cannula; and

activating a vacuum source to remove fluid delivered from the fluid source,

wherein an interruption in the fluid flow to the vacuum source generates a signal that inactivates the power signal source;

wherein the exposed portion of the cannula is optimized to deliver ultrasonic energy at a frequency of 25 kHz to 29 kHz; and

wherein the exposed portion of the cannula is imaged by an ultrasound imaging device during the insertion and the debridement of the musculoskeletal tissue.

12. The method of claim 11 , wherein the delivery device is integrally connected to a removable cassette, wherein the removable cassette provides the connection between the delivery device and the vacuum source, the fluid source, and the power signal source.

13. The method of claim 12 , wherein the delivery device and the cassette are disposable.

14. The method of claim 12 further comprising replacing the delivery device and removable cassette with a second delivery device and a second removable cassette, wherein the second delivery device is integrally connected to the second removable cassette.

15. The method of claim 14 , wherein the second delivery device and the second removable cassette are disposable.

16. The method of claim 11 , wherein fluid flow to the vacuum source is undesirably reduced when there is an occlusion in the fluid flow to the vacuum source.

17. The method of claim 11 , wherein fluid flow to the vacuum source is undesirably reduced when there is an interruption in the fluid flow from the fluid source.

18. The method of claim 11 , further comprising percutaneously inserting the tip portion to a musculoskeletal tissue site.

19. The method of claim 18 , further comprising debriding musculoskeletal tissue with the ultrasonic energy delivered from the cannula while ultrasonically imaging the tip portion of the delivery device.

20. The method of claim 11 , wherein the exposed portion of the cannula comprises a tip that is cylindrical and does not have serrated edges.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 2, 2021
From: SWK FUNDING LLC
To: TENEX HEALTH, INC.
Reel/Frame 055808/0866 →
SECURITY AGREEMENT Recorded Apr 1, 2021
From: TENEX HEALTH, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND, LP
Reel/Frame 055811/0319 →
SECURITY INTEREST Recorded Jul 5, 2016
From: TENEX HEALTH, INC.
To: SWK FUNDING LLC
Reel/Frame 039073/0180 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2015
From: GILL, JAGJIT; BARNES, DARRYL E.; SMITH, JAY; WILEMON, WILLIAM
To: TENEX HEALTH, INC.
Reel/Frame 036396/0770 →
Continuity (3)
Continuation 14514262 · Oct 14, 2014
Continuation 12650832 · Dec 31, 2009
Related Publication 20150351790A1 · Dec 10, 2015